UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDERTHE SECURITIES EXCHANGE ACTOF 1934
(Amendment No. 1)*
KaloBios Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
48344T 10 0
(CUSIP Number)
December 31, 2014
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM BioVentures III, L.P. | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
PN | |||||
Page 2 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM BioVentures III-QP, L.P. | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
PN | |||||
Page 3 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM BioVentures III Parallel Fund, L.P. | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
PN | |||||
Page 4 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM BioVentures III GmbH & Co. Beteiligungs KG | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Germany | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
PN | |||||
Page 5 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM BioVentures Strategic Fund, L.P. | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
PN | |||||
Page 6 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM Asset Management Investors 2005 BVIII LLC | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
OO | |||||
Page 7 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM BioVentures III GP, L.P. | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
PN | |||||
Page 8 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
MPM BioVentures III LLC | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
OO | |||||
Page 9 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
Luke Evnin | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
Page 10 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
Ansbert Gadicke | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
Page 11 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
Nicholas Galakatos | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
Page 12 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
Michael Steinmetz | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
Page 13 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
Kurt Wheeler | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
Page 14 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
Nicholas Simon III | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
Page 15 of 24
| CUSIP No. 48344T 10 0 |
| 1. | Name of Reporting Persons
Dennis Henner | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
0 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
0 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
Page 16 of 24
| Item 1. |
| (a) | Name of Issuer |
KaloBios Pharmaceuticals, Inc.
| (b) | Address of Issuer’s Principal Executive Offices |
260 East Grand Avenue
South San Francisco, CA 94080
| Item 2. |
| (a) | Name of Person Filing |
MPM BioVentures III, LP
MPM BioVentures III-QP, L.P.
MPM BioVentures III Parallel Fund, L.P.
MPM BioVentures III GmbH & Co. Beteiligungs KG
MPM Asset Management Investors 2005 BVIII LLC
MPM BioVentures III GP, L.P.
MPM BioVentures III LLC
MPM BioVentures Strategic Fund, L.P.
Luke Evnin
Ansbert Gadicke
Nicholas Galakatos
Michael Steinmetz
Kurt Wheeler
Nicholas Simon III
Dennis Henner
| (b) | Address of Principal Business Office or, if none, Residence |
c/o MPM Capital LLC
The John Hancock Tower
200 Clarendon Street, 54th Floor
Boston, MA 02116
| (c) | Citizenship |
All entities were organized in Delaware except MPM BioVentures III GmbH & Co. Beteiligungs KG, which was organized in Germany. The individuals are all United States citizens.
| (d) | Title of Class of Securities |
Common Stock
| (e) | CUSIP Number |
48344T 10 0
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable
Page 17 of 24
| Item 4. | Ownership |
| (a) | Amount Beneficially Owned: |
MPM BioVentures III, L.P. | 0 | |||
MPM BioVentures III-QP, L.P. | 0 | |||
MPM BioVentures III Parallel Fund, L.P. | 0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG | 0 | |||
MPM BioVentures Strategic Fund, L.P. | 0 | |||
MPM Asset Management Investors 2005 BVIII LLC | 0 | |||
MPM BioVentures III GP, L.P. | 0 | |||
MPM BioVentures III LLC | 0 | |||
Ansbert Gadicke | 0 | |||
Luke B. Evnin | 0 | |||
Nicholas Galakatos | 0 | |||
Michael Steinmetz | 0 | |||
Kurt Wheeler | 0 | |||
Nicholas Simon III | 0 | |||
Dennis Henner | 0 |
Percent of Class:
MPM BioVentures III, L.P. | 0.0 | % | ||
MPM BioVentures III-QP, L.P. | 0.0 | % | ||
MPM BioVentures III Parallel Fund, L.P. | 0.0 | % | ||
MPM BioVentures III GmbH & Co. Beteiligungs KG | 0.0 | % | ||
MPM BioVentures Strategic Fund, L.P. | 0.0 | % | ||
MPM Asset Management Investors 2005 BVIII LLC | 0.0 | % | ||
MPM BioVentures III GP, L.P. | 0.0 | % | ||
MPM BioVentures III LLC | 0.0 | % | ||
Ansbert Gadicke | 0.0 | % | ||
Luke B. Evnin | 0.0 | % | ||
Nicholas Galakatos | 0.0 | % | ||
Michael Steinmetz | 0.0 | % | ||
Kurt Wheeler | 0.0 | % | ||
Nicholas Simon III | 0.0 | % | ||
Dennis Henner | 0.0 | % |
Page 18 of 24
| (b) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote |
MPM BioVentures III, L.P. | 0 | |||
MPM BioVentures III-QP, L.P. | 0 | |||
MPM BioVentures III Parallel Fund, L.P. | 0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG | 0 | |||
MPM BioVentures Strategic Fund, L.P. | 0 | |||
MPM Asset Management Investors 2005 BVIII LLC | 0 | |||
MPM BioVentures III GP, L.P. | 0 | |||
MPM BioVentures III LLC | 0 | |||
Ansbert Gadicke | 0 | |||
Luke B. Evnin | 0 | |||
Nicholas Galakatos | 0 | |||
Michael Steinmetz | 0 | |||
Kurt Wheeler | 0 | |||
Nicholas Simon III | 0 | |||
Dennis Henner | 0 |
| (ii) | Shared power to vote or to direct the vote |
MPM BioVentures III, L.P. | 0 | |||
MPM BioVentures III-QP, L.P. | 0 | |||
MPM BioVentures III Parallel Fund, L.P. | 0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG | 0 | |||
MPM BioVentures Strategic Fund, L.P. | 0 | |||
MPM Asset Management Investors 2005 BVIII LLC | 0 | |||
MPM BioVentures III GP, L.P. | 0 | |||
MPM BioVentures III LLC | 0 | |||
Ansbert Gadicke | 0 | |||
Luke B. Evnin | 0 | |||
Nicholas Galakatos | 0 | |||
Michael Steinmetz | 0 | |||
Kurt Wheeler | 0 | |||
Nicholas Simon III | 0 | |||
Dennis Henner | 0 |
| (iii) | Sole power to dispose or to direct the disposition of |
MPM BioVentures III, LP | 0 | |||
MPM BioVentures III-QP, L.P. | 0 | |||
MPM BioVentures III Parallel Fund, L.P. | 0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG | 0 | |||
MPM BioVentures Strategic Fund, L.P. | 0 | |||
MPM Asset Management Investors 2005 LLC | 0 | |||
MPM Asset Management III, L.P. | 0 | |||
MPM Asset Management III LLC | 0 | |||
Ansbert Gadicke | 0 | |||
Luke Evnin | 0 | |||
Nicholas Galakatos | 0 | |||
Michael Steinmetz | 0 | |||
Kurt Wheeler | 0 | |||
Nicholas Simon III | 0 | |||
Dennis Henner | 0 |
Page 19 of 24
| (iv) | Shared power to dispose or to direct the disposition of |
MPM BioVentures III, LP | 0 | |||
MPM BioVentures III-QP, L.P. | 0 | |||
MPM BioVentures III Parallel Fund, L.P. | 0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG | 0 | |||
MPM BioVentures Strategic Fund, L.P. | 0 | |||
MPM Asset Management Investors 2005 BVIII LLC | 0 | |||
MPM BioVentures III GP, L.P. | 0 | |||
MPM BioVentures III LLC | 0 | |||
Ansbert Gadicke | 0 | |||
Luke B. Evnin | 0 | |||
Nicholas Galakatos | 0 | |||
Michael Steinmetz | 0 | |||
Kurt Wheeler | 0 | |||
Nicholas Simon III | 0 | |||
Dennis Henner | 0 |
| Item 5. | Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not Applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Not Applicable
| Item 8. | Identification and Classification of Members of the Group |
Not Applicable
| Item 9. | Notice of Dissolution of a Group |
Not Applicable
| Item 10. | Certification |
Not Applicable
Page 20 of 24
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 4, 2015
MPM BIOVENTURES III, L.P. | MPM BIOVENTURES III-QP, L.P. | |||||||
By: | MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||||
| its General Partner | its General Partner | |||||||
By: | MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||||
| its General Partner | its General Partner | |||||||
By: | /s/ Luke Evnin | By: | /s/ Luke Evnin | |||||
| Name: Luke Evnin | Name: Luke Evnin | |||||||
| Title: Series A Member | Title: Series A Member | |||||||
MPM BIOVENTURES III PARALLEL FUND, L.P. | MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG | |||||||
By: | MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||||
| its General Partner | in its capacity as the Managing Limited Partner | |||||||
By: | MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||||
| its General Partner | its General Partner | |||||||
By: | /s/ Luke Evnin | By: | /s/ Luke Evnin | |||||
| Name: Luke Evnin | Name: Luke Evnin | |||||||
| Title: Series A Member | Title: Series A Member | |||||||
MPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLC | MPM BIOVENTURES STRATEGIC FUND, L.P. | |||||||
By: | /s/ Luke Evnin | By: | MPM BioVentures III GP, L.P., | |||||
| Name: Luke Evnin | its General Partner | |||||||
| Title: Manager | ||||||||
| By: | MPM BioVentures III LLC, | |||||||
| its General Partner | ||||||||
| By: | /s/ Luke Evnin | |||||||
| Name: Luke Evnin | ||||||||
| Title: Series A Member | ||||||||
MPM BIOVENTURES III GP, L.P. | MPM BIOVENTURES III LLC | |||||||
By: | MPM BioVentures III LLC, | By: | /s/ Luke Evnin | |||||
| its General Partner | Name: Luke Evnin | |||||||
| Title: Series A Member | ||||||||
By: | /s/ Luke Evnin | |||||||
Name: | Luke Evnin | |||||||
Title: | Series A Member | |||||||
Page 21 of 24
By: | /s/ Luke Evnin | By: | /s/ Ansbert Gadicke | |||||
| Name: Luke Evnin | Name: Ansbert Gadicke | |||||||
By: | /s/ Nicholas Galakatos | By: | /s/ Michael Steinmetz | |||||
| Name: Nicholas Galakatos | Name: Michael Steinmetz | |||||||
By: | /s/ Kurt Wheeler | By: | /s/ Nicholas Simon III | |||||
| Name: Kurt Wheeler | Name: Nicholas Simon III | |||||||
By: | /s/ Dennis Henner | |||||||
| Name: Dennis Henner | ||||||||
EXHIBITS
| A: | Joint Filing Agreement |
Page 22 of 24
